| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals, Inc. (RYTM) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. RYTM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 111.9K | $11.35M | - | |
| Other | 25.5K | $2.58M | - | |
| CEO | 14.1K | $1.43M | - | |
| Other | 8.4K | $849.4K | - | |
| Dir | 7.0K | $713.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2019 | Gottesdiener Keith Michael | CEO And President | Sell | 15,779 | $30.05 | $474,175.75 | -1.4% | |
| Jan 18, 2019 | Gottesdiener Keith Michael | CEO &President | Sell | 10,115 | $30.01 | $303,551.15 | -1.8% | |
| Jan 16, 2019 | Van Der Ploeg Leonardus H.T. | Chief Scientific Officer | Sell | 200 | $30.00 | $6,000.00 | -0.5% | |
| Jan 16, 2019 | Gottesdiener Keith Michael | CEO &President | Sell | 662 | $30.00 | $19,860.00 | -0.1% | |
| Dec 3, 2018 | Gottesdiener Keith Michael | CEO And President | Sell | 563 | $30.00 | $16,890.00 | - | |
| Nov 2, 2018 | Van Der Ploeg Leonardus H.T. | Chief Scientific Officer | Sale+OE | 38,000 | $30.09 | $1,143,420.00 | -47.2% | |
| Nov 2, 2018 | Gottesdiener Keith Michael | CEO And President | Sell | 16,500 | $30.08 | $496,320.00 | -2.8% | |
| Sep 25, 2018 | Van Der Ploeg Leonardus H.T. | Chief Scientific Officer | Sale+OE | 31,800 | $29.80 | $947,539.94 | -8.9% | |
| May 22, 2018 | Orbimed Advisors LLC67 | 10% Owner, See Remarks | Sell | 19,580 | $30.43 | $595,768.40 | -0.4% | |
| May 21, 2018 | Orbimed Advisors LLC67 | 10% Owner | Sell | 131,636 | $30.88 | $4,065,439.72 | -2.3% |